HERSHBERG ROBERT Insider Trading Activity (ATAI)

Summary

Updated Jul 16, 2026

HERSHBERG ROBERT has filed 3 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $496K.

Profile

Robert Hershberg is the President and CEO of ATAI Life Sciences N.V., a clinical-stage biopharmaceutical company focused on developing innovative mental health treatments. He has also held leadership roles at HilleVax, Inc. and Recursion Pharmaceuticals, Inc.

Role	Insider
Notability	30/100

Board memberships

ATAI Life Sciences N.V.
HilleVax, Inc.
Recursion Pharmaceuticals, Inc.

Awards & honors

Leadership in psychedelic-based therapies
Development of mental health treatments
Experience in biopharmaceutical industry

Recent Transactions

Date	Ticker	Company	Code	Shares	Price	Value
2026-07-09	ATAI	AtaiBeckley Inc.	S — Open-market sale	100.0K	$4.96	$496K
2026-07-09	ATAI	AtaiBeckley Inc.	M — Option exercise	51.1K	$1.35	$69K
2026-07-09	ATAI	AtaiBeckley Inc.	M — Option exercise	48.9K	$1.35	$66K
2026-06-22	RXRX	RECURSION PHARMACEUTICALS, INC.	A — Grant or award	88.4K	$0.00
2026-03-07	ADPT	Adaptive Biotechnologies Corp	A — Grant or award	15.6K	$0.00
2025-09-17	HLVX	HilleVax, Inc.	J — Other acquisition / disposition	1.10M	—
2025-06-18	RXRX	RECURSION PHARMACEUTICALS, INC.	A — Grant or award	22.0K	$0.00

Frequently Asked Questions

Who is HERSHBERG ROBERT?

How many SEC Form 4 filings has HERSHBERG ROBERT submitted recently?

3 primary Form 4 filings in the last 90 days, covering 2 companies.

Has HERSHBERG ROBERT been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 1 open-market sales ($496K) across all tracked filings.

Where can I see all of HERSHBERG ROBERT's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

HERSHBERG ROBERT — SEC Form 4 Insider Trading Activity